Yüklüyor......

A Role for Versican in the Development of Leiomyosarcoma

Leiomyosarcoma (LMS) is a mesenchymal cancer that occurs throughout the body. Although LMS is easily recognized histopathologically, the cause of the disease remains unknown. Versican, an extracellular matrix proteoglycan, increases in LMS. Microarray analyses of 80 LMSs and 24 leiomyomas showed a s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Biol Chem
Asıl Yazarlar: Keire, Paul A., Bressler, Steven L., Lemire, Joan M., Edris, Badreddin, Rubin, Brian P., Rahmani, Maziar, McManus, Bruce M., van de Rijn, Matt, Wight, Thomas N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Biochemistry and Molecular Biology 2014
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4256343/
https://ncbi.nlm.nih.gov/pubmed/25320080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M114.607168
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!